Dihydroergotamine
- TRADE NAMES: D.H.E. 45 (Xcel); Dergiflux; Dihydergot; Ergont; Ergovasan; Ikaran; Migranal (Xcel); Orstanorm; Seglor; Verladyn; Verteblan
- INDICATIONS: Prevention of vascular headaches
- CLASS: Ergot alkaloid
- HALF-LIFE: 1.3–3.9 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Almotriptan, Amprenavir, Boceprevir, Ceritinib, Clarithromycin, Crizotinib, Darunavir, Dasatinib, Delavirdine, Efavirenz, Eletriptan, Eluxadoline, Enzalutamide, Erythromycin, Fosamprenavir, Frovatriptan, Indinavir, Itraconazole, Itraconazole, Letermovir, Methylergonovine, Mifepristone, Naratriptan, Nelfinavir, Nilotinib, Ombitasvir/Paritaprevir/Ritonavir, Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir, Posaconazole, Ribociclib, Ritonavir, Rizatriptan, Saquinavir, Sibutramine, Sumatriptan, Telaprevir, Telithromycin, Tipranavir, Troleandomycin, Zolmitriptan
PREGNANCY CATEGORY: X
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
